Prostate cancer screening program beneficial in top decile of polygenic risk score

by

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according to a study published in the April 10 issue of the New England Journal of Medicine.

Leave A Comment

Your email address will not be published. Required fields are marked *